Canopy Growth (NASDAQ:CGC - Get Free Report) is expected to be releasing its Q4 2025 earnings data before the market opens on Friday, May 30th. Analysts expect Canopy Growth to post earnings of ($0.28) per share and revenue of $71.84 million for the quarter.
Canopy Growth Stock Up 7.2%
Shares of NASDAQ:CGC opened at $1.93 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 2.58 and a current ratio of 3.52. The company has a market cap of $354.86 million, a PE ratio of -0.51 and a beta of 0.79. Canopy Growth has a 52 week low of $0.77 and a 52 week high of $10.04. The firm has a 50 day simple moving average of $1.21 and a 200 day simple moving average of $2.14.
Institutional Investors Weigh In On Canopy Growth
A hedge fund recently raised its stake in Canopy Growth stock. Jones Financial Companies Lllp boosted its stake in Canopy Growth Co. (NASDAQ:CGC - Free Report) by 10,308.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 969,533 shares of the company's stock after buying an additional 960,218 shares during the quarter. Jones Financial Companies Lllp owned approximately 0.53% of Canopy Growth worth $882,000 at the end of the most recent quarter. 3.33% of the stock is owned by hedge funds and other institutional investors.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.